Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach

• Published in: Frontiers in endocrinology (Lausanne) Vol. 12; p. 641336
• Main Authors: Yang, Meng-Ting, Chang, Wei-Hung, Kuo, Tien-Fen, Shen, Ming-Yi, Yang, Chu-Wen, Tien, Yin-Jing, Lai, Bun-Yueh, Chen, Yet-Ran, Chang, Yi-Cheng, Yang, Wen-Chin
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 28.04.2021
• Subjects: Adult; Aged; Aged, 80 and over; Biomarkers - blood; Blood Glucose - analysis; Body Mass Index; Cations; Cholesterol - metabolism; Chromatography, Ion Exchange; Combinatorial Chemistry Techniques; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - physiopathology; diagnosis; Endocrinology; Female; Glycated Hemoglobin - biosynthesis; Humans; Insulin - blood; Insulin Resistance; Male; marker; Middle Aged; Prediabetic State - blood; Proteomics; Sensitivity and Specificity; serum protein; Triglycerides - metabolism; type 2 diabetes; Young Adult; diagnosis; serum protein; type 2 diabetes; proteomics; marker
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2021.641336

Reliable protein markers for pre-diabetes in humans are not clinically available. In order to identify novel and reliable protein markers for pre-diabetes in humans, healthy volunteers and patients diagnosed with pre-diabetes and stroke were recruited for blood collection. Blood samples were collected from healthy and pre-diabetic subjects 12 h after fasting. BMI was calculated from body weight and height. Fasting blood glucose (FBG), glycated hemoglobin (Hb A1C ), triglyceride (TG), total cholesterol, high-density lipoprotein, low-density lipoprotein (LDL), insulin and albumin were assayed by automated clinical laboratory methods. We used a quantitative proteomics approach to identify 1074 proteins from the sera of pre-diabetic and healthy subjects. Among them, 500 proteins were then selected using Mascot analysis scores. Further, 70 out of 500 proteins were selected via volcano plot analysis according to their statistical significance and average relative protein ratio. Eventually, 7 serum proteins were singled out as candidate markers for pre-diabetes due to their diabetic relevance and statistical significance. Immunoblotting data demonstrated that laminin subunit alpha 2 (LAMA2), mixed-lineage leukemia 4 (MLL4), and plexin domain containing 2 (PLXDC2) were expressed in pre-diabetic patients but not healthy volunteers. Receiver operating characteristic curve analysis indicated that the combination of the three proteins has greater diagnostic efficacy than any individual protein. Thus, LAMA2, MLL4 and PLXDC2 are novel and reliable serum protein markers for pre-diabetic diagnosis in humans.